A Worldwide Business Report
from MedMarket Diligence:
Download the report
by purchasing direct from us
Via Google Wallet:
REPORT: Diabetes Management Worldwide
Products, Technologies, Markets and
Diabetes Management Worldwide,
· 67 Exhibits
· 123 Company Profiles
· July 2010
· Report #D510
online or via
Price: $1,950 for print or PDF; $2,150 for both.
Worldwide report on products, trends, competitors
and markets for diabetes management.
This report details the worldwide
incidence and prevalence by country/region of Type 1 and Type 2 diabetes and
details the current and projected market for diagnostic and therapeutic
products in the management of diabetes, including anti-diabetic drugs,
alternative insulin types, blood glucose monitoring (including
monitoring devices), insulin pumps, and other established and emerging
products in diabetes management. The report provides an emphasis of
detail on the status of development of novel products including noninvasive
monitoring, oral/inhaled/other insulin delivery. The report details the
clinical and technology developments underlying this huge and evolving
worldwide market, with data on products in development and on the market;
market size and forecast; competitor market shares; competitor profiles; and
Separate size, growth and competitor share data
are presented for the U.S., European, Asia/Pacific and Rest of World. The report profiles active companies including detailed
profile information on major competitors, brief profiles of companies with
less sizeable current or potential positions in the market, plus
additional profiles of companies with novel or advanced research activities
in the market.
See coverage of
in advanced medical technologies blog
The report establishes
the current worldwide market size for major technology segments as a
baseline for and projecting growth in the market over a ten-year forecast.
The report also assesses and projects the composition of the market as
technologies gain or lose relative market performance over this period.
Products & Technologies Covered:
Table of Contents
Some Diabetes Basics
A Large and Growing Market
A Many-Sided Market
Pharmaceuticals for Diabetes Insulin
Oral Antidiabetic Drugs
The Pharmaceutical Diabetes Market
Insulin Administration Devices
Medical Devices for Diabetes
Total Diabetes Market
The Diabetes Industry
Medical Device Companies
SECTION 1: ABOUT DIABETES
1.1 What is Diabetes?
1.2 Blood Sugar Regulation
1.3 Main Types of Diabetes
1.3.1 Type 1 Diabetes
1.3.2 Type 2 Diabetes
1.3.3 Gestational Diabetes
1.3.4 Obesity-Related Type 2 Diabetes in Children
1.3.5 Mature-Onset Diabetes of the Young (MODY)
1.3.6 Other Diabetic States
1.4.1 Glucose Tests
1.4.2 Official Criteria
1.4.3 Differential Diagnosis
184.108.40.206 Type 1 Diabetes
220.127.116.11 Type 2 Diabetes
1.5 Current Treatment
1.5.1 Type 1 Diabetes
1.5.2 Type 2 Diabetes
1.6 Future Treatment Approaches
1.7 Treatment Monitoring
1.7.1 Blood Sugar Control
1.7.2 The Diabetes Control and Complications Trial
1.7.3 Glycated Hemoglobin (HbA1c)
1.8 Incidence and Prevalence of Diabetes (Type 1 & Type 2)
18.104.22.168 Type 1
22.214.171.124 Type 2
1.8.2 United States
1.9 Diabetic Complications
1.10 Metabolic Syndrome
SECTION 2: PRODUCTS USED IN DIAGNOSIS AND MONITORING
2.1 Blood Glucose Monitoring Devices: Suppliers and Products
2.1.2 Blood Sampling Devices
2.1.3 Blood Glucose Monitors
2.1.4 New Developments in Glucose Testing
2.2 Artificial Pancreas
2.3 Other Testing Approaches
2.3.1 Hemoglobin A1c
126.96.36.199 Hemoglobin A1c Meters
188.8.131.52 Hemoglobin A1c Kits
2.4 Software Programs for Diabetes Monitoring
2.4.1 Web Software
2.4.2 Commercial Software
SECTION 3: PRODUCTS USED IN TREATMENT
184.108.40.206 Bovine and Porcine Insulin
220.127.116.11 Humanized Insulin
3.1.2 Companies Supplying Insulin
3.1.3 Insulin Delivery
18.104.22.168 Insulin Syringe Manufacturers
22.214.171.124 Manufacturers of Insulin Pens
126.96.36.199 Injector Manufacturers
3.1.4 Inhaled insulin
3.1.5 Insulin Pumps
188.8.131.52 What is an Insulin Pump?
184.108.40.206 The Infusion Set
220.127.116.11 Candidates for Pump Therapy
3.1.6 Companies Supplying Insulin Pumps
3.2 Oral Hypoglycemic Agents
3.2.3 Alpha-Glucosidase Inhibitor
3.2.5 Prandial Glucose Regulators/Meglitinides
3.2.6 Incretin Mimetics/GLP-1 Analogs
3.2.7 DPP-4 Inhibitors
3.2.8 Amylin Mimetic
3.2.9 SGLT2 Inhibitors
SECTION 4: NOVEL APPROACHES TO DIABETES MANAGEMENT
4.1 Pancreas Transplants
4.2 Islet Cell Transplants
4.2.1 Edmonton Protocol
4.2.2 Improving Islet Cell Transplantation
4.2.3 Living-Donor Islet Cell Transplant
4.3 Stem Cell Developments
4.3.1 Embryonic Stem Cells
4.3.2 Cord Blood Stem Cells
4.3.3 Adult Stem Cells
4.4 Antibody Treatment
4.6 Novel Drugs
4.6.1 PPARα/γ Ligands (PPAR Co-agonists)
4.6.2 SGLT1/SGLT2 Inhibitors
4.7 Continuous Glucose Monitoring
4.7.1 Optical Glucose Sensor and Optical Biosensors
4.7.2 Sensor Based on Carbon Nanotubes
SECTION 5: THE DIABETES MARKET
5.1 Worldwide Market
5.1.3 Regional Segmentation
5.2 Market Analysis by Product Category
5.2.1 Monitoring Products
18.104.22.168 Major Suppliers
5.2.2 Insulins and Insulin Delivery Devices
22.214.171.124 Major Suppliers
126.96.36.199.2 Syringes and Other Insulin
188.8.131.52.3 Insulin Pumps
5.2.3 Anti-diabetic Drugs
184.108.40.206 Major Suppliers
5.4 Global Markets by Region
5.4.1 United States
5.4.4 Rest of World
SECTION 6: COMPANY PROFILES
6.1 Leading Companies
6.1.3 Becton Dickinson
6.1.4 Bristol-Myers Squibb
6.1.5 Eli Lilly
6.1.7 Johnson & Johnson
6.1.9 Merck & Co. / Merck Sharp & Dohme
6.1.10 Merck KGaA / Merck Serono
6.1.11 Novartis (Sandoz)
6.1.12 Novo Nordisk
6.1.13 Roche (Roche Diabetes Care)
6.1.15 Takeda Pharmaceutical Company Limited
6.2 Other Companies
6.2.1 77 Elektronika
6.2.2 ACON Laboratories
6.2.3 Activa Brand Products, Inc.
6.2.4 AgaMatrix, Inc.
6.2.5 AiMedics Pty Ltd.
6.2.6 Alkermes Inc.
6.2.8 Amylin Pharmaceuticals
6.2.9 Antares Pharma
6.2.10 Apex Biotechnology Ltd.
6.2.11 Arena Pharmaceuticals
6.2.12 ArKal Medical
6.2.13 ARKRAY USA, Inc. (formerly HypoGuard)
6.2.14 Asante Solutions, Inc.
6.2.15 B. Braun Melsungen AG
6.2.18 Bioject Medical Technologies Inc.
6.2.19 Biorasis Inc. (aka Bio-Orasis)
6.2.20 Biosign Technologies Inc.
6.2.22 Boehringer Ingelheim Pharmaceuticals, Inc.
6.2.23 Calibra Medical, Inc.
6.2.24 Calisto Medical, Inc.
6.2.25 Cascade Metrix, Inc.
6.2.27 CeQur SA
6.2.28 CPEX Pharmaceuticals
6.2.29 DARA BioSciences, Inc.
6.2.30 DexCom, Inc.
6.2.31 Diabetes Technologies, Inc.
6.2.32 Diamyd Medical AB
6.2.33 Diosynth Biotechnology
6.2.34 Echo Therapeutics
6.2.36 EPS Bio Technology Corp.
6.2.37 Eumed Biotechnology Co., Ltd.
6.2.38 Exsulin Corp.
6.2.40 FivePrime Therapeutics
6.2.41 FlexSite Diagnostics
6.2.42 Freedom Meditech
6.2.43 Generex Biotechnology Corp.
6.2.44 Geron Corp.
6.2.45 GlucoPlus, Inc.
6.2.46 GluMetrics, Inc.
6.2.47 HemoCue AB
6.2.48 HMD BioMedical Inc. (aka Beijing HMD BioMedical
6.2.49 Home Diagnostics Inc.
6.2.50 INJEX - Equidyne Systems (DBA) (Owned by HNS
6.2.51 InLight Solutions Inc.
6.2.52 Insulet Corporation
6.2.53 Integrity Applications Ltd.
6.2.54 InteKrin Therapeutics
6.2.55 Kumetrix Inc.
6.2.56 Laboratorios Beta
6.2.57 Lein Applied Diagnostics Ltd.
6.2.58 Ligand Pharmaceuticals Inc.
6.2.59 LighTouch Medical, Inc.
6.2.60 Living Cell Technologies, Ltd.
6.2.61 MannKind Corp.
6.2.62 Medingo Ltd.
6.2.63 Medipacs, Inc.
6.2.66 NanoMega Medical
6.2.67 Nektar Therapeutics
6.2.68 NiliMEDIX Ltd.
6.2.69 Nipro Diabetes Systems Inc.
6.2.70 OK Biotech Co. Ltd.
6.2.71 Owen Mumford
6.2.73 Phenomix Corporation
6.2.74 Polymer Technology Systems Inc.
6.2.75 Prodigy Diabetes Care, LLC
6.2.76 Quotient Diagnostics Ltd.
6.2.77 Rheamed Biotechnology Co.
6.2.78 Sanwa Kagaku Kenkyusho Co. Ltd.
6.2.79 Sensors for Medicine and Science, Inc.
6.2.80 Sensys Medical
6.2.81 Sernova Corp.
6.2.82 Servier Laboratories
6.2.83 Siemens Healthcare
6.2.84 Sirna Therapeutics
6.2.85 Skyup Technology Corp.
6.2.86 SmartCells, Inc.
6.2.87 Smiths Medical
6.2.88 SOOIL Development Co., Ltd.
6.2.89 Syndexa Pharmaceuticals Corp.
6.2.90 TaiDoc Technology Corporation
6.2.91 Tandem Diabetes Care, Inc.
6.2.92 Terumo Medical Corporation
6.2.93 Theratechnologies Inc.
6.2.94 Thermalin Diabetes, Inc.
6.2.95 Tolerx Inc.
6.2.96 Tyson Bioresearch
6.2.97 Ultradian Diagnostics
6.2.98 Unilife Corp.
6.2.99 US Diagnostics Inc.
6.2.100 Valeritas, Inc.
6.2.101 Vaxine Pty Ltd.
6.2.102 VeraLight Inc.
6.2.103 Verva Pharmaceuticals
6.2.105 VivoMedical Inc.
6.2.106 Wockhardt Ltd.
6.2.108 Ypsomed AG
APPENDIX: LIST OF COMPANIES
List of Exhibits
Exhibit ES-1: Total Diabetes Market, 2009
Exhibit ES-2: Overall Diabetes Products Market by
Geographical Region, 2009
Exhibit 1-1: Threshold Glucose Levels Indicative of
Exhibit 1-2: Main Brands and Types of Insulin
Exhibit 1-3: Leading Oral Diabetes Treatments
Exhibit 1-4: Regional Estimates for Diabetes (Age 20-79
Years), 2010 and 2030
Exhibit 1-5: Type 1 Diabetes in Children by Region, 2010
Exhibit 1-6: Differences in the Prevalence of Type 2
Diabetes among Selected Ethnic Groups, 2007
Exhibit 1-7: Prevalence of Diagnosed and Undiagnosed
Diabetes in the United States, 2007
Exhibit 1-8: Estimated Prevalence of Type 2 Diabetes in
Selected Western European Countries, 2010, Ages 2079
Exhibit 2-1: Suppliers of Blood Lancets
Exhibit 2-2: Suppliers of Blood Glucose Monitors
Exhibit 2-3: Developers of Alternative Blood Glucose Testing
Exhibit 2-4: Examples of Commercial Software Programs
Exhibit 3-1: Leading Suppliers and Developers of Insulin
Exhibit 3-2: Suppliers of Syringes and Similar Delivery
Exhibit 3-3: Manufacturers and Developers of Insulin Pens
Exhibit 3-4: Manufacturers of Insulin Injectors
Exhibit 3-5: Suppliers of Insulin Pump Systems
Exhibit 3-6: Sulfonylureas
Exhibit 3-7: Oral Hypoglycemic Agents (OHAs)
Exhibit 4-1: Islet Transplants and Related Approaches
Exhibit 4-2: Companies in Stem Cell Research
Exhibit 4-3: Suppliers of Continuous Blood Glucose Monitors
Exhibit 5-1: Regional Estimates for Diabetes (2079 Years),
2010 and 2030
Exhibit 5-2: Worldwide Market for Diabetes Products ,
Exhibit 5-3: Worldwide Market for Diabetes Products, by
Exhibit 5-4: Overall Diabetes Products Market by
Geographical Region, 2009
Exhibit 5-5: Worldwide Market for Blood Glucose Meters,
Exhibit 5-6: Worldwide Market for Lancets, 20092018
Exhibit 5-7: Worldwide Market for Test Strips, 20092018
Exhibit 5-8: Worldwide Market for Continuous Blood Glucose
Exhibit 5-9: Market Shares of the Leading Suppliers of Blood
Glucose Meters, 2009
Exhibit 5-10: Market Shares of the Leading Suppliers of
Exhibit 5-11: Market Shares of the Leading Suppliers of Test
Strips (only), 2009
Exhibit 5-12: Market Shares of the Leading Suppliers of
Continuous Blood Glucose Monitors, 2009
Exhibit 5-13: Worldwide Market for Insulin, 20092018
Exhibit 5-14: Worldwide Market for Insulin Syringes and
Other Delivery Devices, 20092018
Exhibit 5-15: Worldwide Market for Insulin Pumps, 20092018
Exhibit 5-16: Market Shares of the Leading Suppliers of
Exhibit 5-17: Market Shares of the Leading Suppliers of
Insulin Syringes and Other Delivery Devices, 2009
Exhibit 5-18: Market Shares of the Leading Suppliers of
Insulin Pumps, 2009
Exhibit 5-19: Leading Manufacturers of Anti-Diabetic Drugs,
Exhibit 5-20: U.S. Market for Diabetes Management, 2009-2018
Exhibit 5-21: U.S. Market for Diabetes Management, by
Product Segment, 2009-2018
Exhibit 5-22: European Market for Diabetes Management,
Exhibit 5-23: European Market for Diabetes Management, by
Product Segment, 2009-2018
Exhibit 5-24: Asia/Pacific Market for Diabetes Management,
Exhibit 5-25: Asia/Pacific Market for Diabetes Management,
by Product Segment, 2009-2018
Exhibit 5-26: Rest of World Market for Diabetes Management,
Exhibit 5-27: Rest of World Market for Diabetes Management,
by Product Segment, 2009-2018
Exhibit 6-1: Financial Data for Abbott Laboratories, Year
Ended December 31, 20082009, USD Millions
Exhibit 6-2: Estimated Bayer AG Revenues, 2009
Exhibit 6-3: Estimated Bayer Diabetes Care Products
Exhibit 6-4: Becton Dickinson Sales by Division, 20082009,
Exhibit 6-5: Year-End Financial Data for GlaxoSmithKline,
20082009, £ Millions
Exhibit 6-6: Financial Data for Johnson & Johnsons Diabetes
Care Business by Geographical Region, 20082009, $ Millions
Exhibit 6-7: Financial Data for Novartis, 20082009, $
Exhibit 6-8: Sales of Novo Nordisks Diabetes Care Products,
2009, DKK Millions
Exhibit 6-9: Financial Data for Roche, 20082009, Swiss
Exhibit 6-10: Sanofi-Aventis Selected Diabetes Products
Exhibit 6-11: Sanofi-Aventis Year-End Financial Data,
Exhibit 6-12: Takedas Diabetes-Related R&D Activities as of
Exhibit 6-13: Financial Data for Takeda Pharmaceutical
Exhibit 6-14: Financial Data for B. Braun, 20082009,
Exhibit 6-15: Unilife Corp. 2009 Revenues and Profits (000),
Year End June 30, 2009
Exhibit 6-16: Ypsomed Financial Overview (CHF, 000)
Products, Technologies, Markets and Opportunities in Diabetes
Management Worldwide, 2009-2018. (July
Price: $1,950 for print or PDF; $2,150 for both.
online or via order form.
MedMarket Diligence Reports are
produced through primary and secondary research. Data is gathered from published
sources on products and technologies on the market and under development.
Clinicians and industry representatives are interviewed for their knowledge
and insights on product development, market development, clinical practice and
trends associated with the evolving use of technologies. Secondary data is used
to corroborate and support assessments and projections. Reports are written
and researched by industry insiders, whose familiarity with the companies, industry
dynamics and other marketplace specifics facilitate the research process and
ensure high quality and thorough reports.
Or contact: Patrick Driscoll, (949) 891-1753 or patrick <at>
mediligence <dot> com.
Copyright © 2010 MedMarket Diligence, LLC. All rights